iShares Health Innovation Active ETF (BMED)

Assets	$7.18M
Expense Ratio	0.55%
PE Ratio	24.56
Shares Out	240,000
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	8,124
Open	30.49
Previous Close	30.40
Day's Range	30.49 - 30.78
52-Week Low	20.57
52-Week High	30.95
Beta	0.82
Holdings	136
Inception Date	Sep 29, 2020

About BMED

Fund Home Page

The iShares Health Innovation Active ETF (BMED) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: BMED
• ETF Provider: BlackRock

Top 10 Holdings

28.15% of assets

Name	Symbol	Weight
Johnson & Johnson	JNJ	3.31%
Roche Holding AG	ROG	3.31%
Medtronic plc	MDT	3.24%
Exact Sciences Corporation	EXAS	2.99%
Gilead Sciences, Inc.	GILD	2.76%
BlackRock Cash Funds Treasury SL Agency	XTSLA	2.74%
Edwards Lifesciences Corporation	EW	2.65%
Abbott Laboratories	ABT	2.55%
Guardant Health, Inc.	GH	2.45%
Natera, Inc.	NTRA	2.14%

Performance

BMED had a total return of 22.28% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.59%.